Spikevax XFG▼ (mRNA-1273.262) 0.1 mg/mL dispersion for injection
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.Spikevax XFG is a vaccine used to prevent COVID-19 caused by SARS-CoV-2. It is given to adults and children aged 6 months and older. The active substance in Spikevax XFG is mRNA encoding the SARS-CoV-2 spike protein. The mRNA is embedded in SM-102 lipid nanoparticles. As Spikevax XFG does not contain the virus, it cannot give you COVID-19. Spikevax XFG contains messenger ribonucleic acid (mRNA) (mRNA-1273.262) that encodes the spike protein of the XFG strain of the virus.
Patient information leaflet for multi-dose vial
Summary of Product Characteristics for multi-dose vial
Spikevax JN.1▼ (mRNA-1273.167) dispersion for injection
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Spikevax JN.1 is a vaccine used to prevent COVID-19 caused by SARS-CoV-2. It is given to adults and children aged 6 months and older. The active substance in the vaccine is ribonucleic acid (RNA) encoding the SARS-CoV-2 spike protein. The RNA is embedded in SM-102 lipid nanoparticles. Spikevax JN.1 contains messenger ribonucleic acid (mRNA) (mRNA-1273.167) that encodes the spike protein of the JN.1 strain of the virus. As Spikevax JN.1 does not contain the virus, it cannot give you COVID-19.
Patient information leaflet for pre-filled syringe
Summary of Product Characteristics for pre-filled syringe
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.